\-\ Texto\\:\\ \ \(0\)\
\-\ mammogram\\:\\ \\ heterogeneously\\ dense\\ breast\\ tissue\\ with\\ two\\ well\\-defined\\ round\\ masses\\ in\\ the\\ subareolar\\/upper\\ outer\\ quadrant\\.\ \(0\)\
\-\ ultrasound\\:\\ \\ two\\ hypoecohic\\ solid\\ masses\\.\ \(0\)\
\-\ invasive\\ ductal\\ carcinoma\ \(7\)\
\-\ cysts\\ \\(pre\\-us\\)\ \(0\)\
\-\ fibroadenoma\ \(22\)\
\-\ multiple\\ breast\\ cancers\ \(0\)\
\-\ multiple\\ papillomas\ \(2\)\
\-\ 37\\ y\\.o\\.\\ female\\ presents\\ to\\ the\\ breast\\ care\\ clinic\\ with\\ multiple\\ right\\ breast\\ masses\\.\ \(0\)\
\-\ well\\-circumcribed\\ masses\\ are\\ almost\\ always\\ benign\\,\\ however\\ 5\\%\\ of\\ these\\ masses\\ can\\ be\\ carcinoma\\.\\ cysts\\ are\\ the\\ most\\ common\\ well\\-circumscribed\\ masses\\ seen\\ in\\ women\\ between\\ the\\ ages\\ of\\ 35\\ to\\ 50\\.\\ fibroadenomas\\ are\\ the\\ most\\-common\\ solid\\ masses\\ seen\\ on\\ mammography\\.\\ multiple\\ masses\\ are\\ also\\ a\\ sign\\ of\\ benignity\\.\\ aside\\ from\\ cysts\\ and\\ fibroadenomas\\,\\ they\\ may\\ also\\ be\\ multiple\\ papillomas\\.\\ less\\ likely\\ is\\ metastatic\\ disease\\.\\ multi\\-focal\\ primary\\ breast\\ cancers\\ are\\ seen\\ as\\ ill\\-defined\\ or\\ stellate\\ lesions\\ that\\ are\\ suspicious\\ in\\ appearance\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ masses\\:\\ 0\\.1627375998871035\ \(0\)\
\-\ breast\\:\\ 0\\.11100556140248424\ \(0\)\
\-\ fibroadenomas\\:\\ 0\\.10149409171172391\ \(0\)\
\-\ papillomas\\:\\ 0\\.09892618246110484\ \(0\)\
\-\ cancers\\:\\ 0\\.07256277151882891\ \(0\)\
\-\ cysts\\:\\ 0\\.0707209496372824\ \(0\)\
\-\ multiple\\:\\ 0\\.06337345082673482\ \(0\)\
\-\ subareolar\\/upper\\:\\ 0\\.06208111566173591\ \(0\)\
\-\ hypoecohic\\:\\ 0\\.06208111566173591\ \(0\)\
\-\ pre\\-us\\:\\ 0\\.06208111566173591\ \(0\)\
\-\ well\\-circumcribed\\:\\ 0\\.06208111566173591\ \(0\)\
\-\ most\\-common\\:\\ 0\\.06208111566173591\ \(0\)\
\-\ benignity\\:\\ 0\\.05434440940350978\ \(0\)\
\-\ multi\\-focal\\:\\ 0\\.05434440940350978\ \(0\)\
\-\ 50\\.\\:\\ 0\\.050747045855861955\ \(0\)\
\-\ are\\:\\ 0\\.049220022782940916\ \(0\)\
\-\ solid\\:\\ 0\\.048004882429667314\ \(0\)\
\-\ stellate\\:\\ 0\\.04519452923357836\ \(0\)\
\-\ aside\\:\\ 0\\.04212890901345269\ \(0\)\
\-\ fibroadenoma\\:\\ 0\\.03812902142467847\ \(0\)\
\-\ seen\\:\\ 0\\.035675231304246977\ \(0\)\
\-\ heterogeneously\\:\\ 0\\.035431892887663644\ \(0\)\
\-\ mammography\\:\\ 0\\.034967400156735495\ \(0\)\
\-\ two\\:\\ 0\\.03446945405092966\ \(0\)\
\-\ ages\\:\\ 0\\.03412131345362237\ \(0\)\
\-\ carcinoma\\:\\ 0\\.034111657324167134\ \(0\)\
\-\ ill\\-defined\\:\\ 0\\.03398967871410017\ \(0\)\
\-\ outer\\:\\ 0\\.03196374862641157\ \(0\)\
\-\ well\\-circumscribed\\:\\ 0\\.03186661255505709\ \(0\)\
\-\ mammogram\\:\\ 0\\.03140006758645709\ \(0\)\
\-\ well\\-defined\\:\\ 0\\.030962519832182397\ \(0\)\
\-\ always\\:\\ 0\\.030962519832182397\ \(0\)\
\-\ invasive\\:\\ 0\\.030237534133221534\ \(0\)\
\-\ 37\\:\\ 0\\.030237534133221534\ \(0\)\
\-\ women\\:\\ 0\\.02923999528066501\ \(0\)\
\-\ almost\\:\\ 0\\.029108360541142807\ \(0\)\
\-\ suspicious\\:\\ 0\\.028979141254747057\ \(0\)\
\-\ dense\\:\\ 0\\.028425316414471612\ \(0\)\
\-\ ductal\\:\\ 0\\.02836638507876375\ \(0\)\
\-\ 35\\:\\ 0\\.027695186629437516\ \(0\)\
\-\ clinic\\:\\ 0\\.0268894799310027\ \(0\)\
\-\ round\\:\\ 0\\.025996862285656615\ \(0\)\
\-\ also\\:\\ 0\\.02372703653056551\ \(0\)\
\-\ care\\:\\ 0\\.021705472866681355\ \(0\)\
\-\ they\\:\\ 0\\.021682719200614833\ \(0\)\
\-\ quadrant\\:\\ 0\\.021178703760465174\ \(0\)\
\-\ sign\\:\\ 0\\.02084821480115543\ \(0\)\
\-\ benign\\:\\ 0\\.020767960331219727\ \(0\)\
\-\ less\\:\\ 0\\.020379859185371003\ \(0\)\
\-\ between\\:\\ 0\\.019073912226931295\ \(0\)\
\-\ be\\:\\ 0\\.018559953849914494\ \(0\)\
\-\ ultrasound\\:\\ 0\\.017852975950748615\ \(0\)\
\-\ primary\\:\\ 0\\.01782664973870209\ \(0\)\
\-\ 5\\:\\ 0\\.01760676353833918\ \(0\)\
\-\ y\\.o\\:\\ 0\\.01736886924356831\ \(0\)\
\-\ appearance\\:\\ 0\\.017210609695314377\ \(0\)\
\-\ likely\\:\\ 0\\.016973872999546877\ \(0\)\
\-\ however\\:\\ 0\\.016756113067585003\ \(0\)\
\-\ lesions\\:\\ 0\\.01610958103059118\ \(0\)\
\-\ \\:\\:\\ 0\\.015919363605502324\ \(0\)\
\-\ common\\:\\ 0\\.015748360647580263\ \(0\)\
\-\ these\\:\\ 0\\.015660878112379154\ \(0\)\
\-\ metastatic\\:\\ 0\\.015148657771944298\ \(0\)\
\-\ tissue\\:\\ 0\\.014263529496145027\ \(0\)\
\-\ \\%\\:\\ 0\\.014037472065816955\ \(0\)\
\-\ most\\:\\ 0\\.013893205223437156\ \(0\)\
\-\ can\\:\\ 0\\.0136494531864019\ \(0\)\
\-\ may\\:\\ 0\\.01319949555562059\ \(0\)\
\-\ female\\:\\ 0\\.01237155120737911\ \(0\)\
\-\ presents\\:\\ 0\\.012293269686675535\ \(0\)\
\-\ that\\:\\ 0\\.010394230482808615\ \(0\)\
\-\ disease\\:\\ 0\\.009836179867716227\ \(0\)\
\-\ as\\:\\ 0\\.009102658492212168\ \(0\)\
\-\ from\\:\\ 0\\.008918561360240933\ \(0\)\
\-\ in\\:\\ 0\\.008902758383244821\ \(0\)\
\-\ or\\:\\ 0\\.007052977105378222\ \(0\)\
\-\ right\\:\\ 0\\.006349519078242371\ \(0\)\
\-\ to\\:\\ 0\\.00601504378088713\ \(0\)\
\-\ on\\:\\ 0\\.005097824030742451\ \(0\)\
\-\ \\(\\:\\ 0\\.005087054410168032\ \(0\)\
\-\ \\)\\:\\ 0\\.005024913324741585\ \(0\)\
\-\ the\\:\\ 0\\.0048679325599868244\ \(0\)\
\-\ is\\:\\ 0\\.003959794213976941\ \(0\)\
\-\ \\,\\:\\ 0\\.003812817824187146\ \(0\)\
\-\ a\\:\\ 0\\.0027929563508352203\ \(0\)\
\-\ \\.\\:\\ 0\\.0024999673307990336\ \(0\)\
\-\ of\\:\\ 0\\.002461347904182854\ \(0\)\
\-\ with\\:\\ 0\\.0016479461421111232\ \(0\)\
\-\ and\\:\\ 0\\.0012676690544522425\ \(0\)\
